Investor
Info
-Annual Report
-Annual Report
DNA Sequencing
-DNA Sequencing
-Genome Sequencing
-Computer-based
Homology Searches
Nucleic Acid Synthesis
-DNA/RNA/PNA Synthesis
-Gene Synthesis
Peptide Technologies
-Peptide Synthesis
-Amino Acid Synthesis
-Peptide Sequencing
Protein Technologies
-Protein (N- and C- Terminal) Sequencing
-Monoclonal & Polyclonal Antibodies
-Purification
-Overexpression Projects
-Peptide Mapping
-Computer-based homology searches
Molecular Biology
-Plasmid Preparation
-Cloning & Overexpression Projects
-Site-directed Mutagenesis
-Genomic or cDNA Libraries
-Library Screening
-Northern or Southern Blot Analysis
-Computer Based Homology Searches
Genetic Testing Services
-Human Genetic Analysis
-Veterinary Genetic Analysis
-DNA Identity testing (CODIS Databasing)
-DNA Fingerprinting
Biophysical Analysis
-Mass
Spectrometry
-Calorimetry
Text Home Page
Graphics
Version
| The Executive Officers |
|
| Executive Officers | |
| Richard J. Freer, Ph.D. Chairman of the Board |
Robert B. Harris, Ph.D. President |
| Thomas R. Reynolds Senior Vice President and Secretary |
James H. Brennan, MBA Controller |
| Directors |
|
| Richard
J. Freer, Ph.D. Chairman of the Board |
Robert
B. Harris, Ph.D. President |
| Thomas R. Reynolds Senior Vice President and Secretary |
Raymond Cypess, D.M.V., Ph.D. President and CEO, American Type Culture Collection |
| Mr. Everette G.
("Buddy") Allen, Jr. Chairman and Senior Partner, Hirschler, Fleischer, Weinberg, Cox and Allen. Mr. L. McCarthy ("Mac") Downs, III Chairman, Anderson and Strudwick, Inc. |
Dr. Donald
McAfee Chairman and Chief Technical Officer, Discovery Therapeutics Mr. Samuel P. Sears, Jr. Attorney, Business Development |
Overview of CBI CBI was founded in 1992 by four experienced research scientists to provide sophisticated research and development support services on a contract basis to the biotechnology industry. CBI's customers consist of private companies, academic institutions, and government agencies, all of which use biological processes to develop products for health care, agricultural, and other purposes. CBI has developed a strong reputation as a leading provider of biotechnology research and development analytical services. Providing a wide range of services is an important element of our strategy. There are few major competitors which offer integrated DNA/RNA and protein/peptide technologies, and none that offer these technologies combined with sophisticated biophysical techniques, such as calorimetery, spectroscopy, and mass spectral analysis. Thus, CBI can provide "one stop shopping" for biotechnology services. |
|
Commonwealth Biotechnologies, Inc.
601 Biotech Drive, Richmond, VA 23235
800-735-9224 / FAX: 804-648-2461
Toll-Free FAX on Demand: (877) FAX-4-CBI
email: [email protected]
601 Biotech Drive, Richmond, VA 23235
800-735-9224 / FAX: 804-648-2461
Toll-Free FAX on Demand: (877) FAX-4-CBI
email: [email protected]
© Internet Creations